Metrics Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf Countries
Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf Countries
cost-minimization analysissubcutaneous daratumumabnewly diagnosed multiple myelomaGulf countriesQatarOmanUnited Arab Emirates
• https://doi.org/10.36469/001c.120288 Pageviews and PDF downloads
| Top Countries | |
|---|---|
| 27 | |
| 19 | |
| 8 | |
| 7 | |
| 6 | |
| 5 | |
| 5 | |
| 5 | |
| 4 | |
| 4 | |